天天操夜夜操,一超碰,亚洲AV片在线观看,亚洲骚国产精品中文

歡迎蒞臨南京沃博生物科技有限公司官方網(wǎng)站!

當前位置: 首頁 - 產品專區(qū) - 熱銷產品

In vivo-jetRNA?+ transfection reagent

貨號 101000122 售價(元) 咨詢
規(guī)格 1 mL CAS號
  • 產品簡介
  • 相關產品

產品信息

貨號

名稱

規(guī)格

緩沖液規(guī)格

101000122

In vivo-jetRNA?+ transfection reagent

1 mL

60ml

產品簡介:

Reagent

in vivo-jetRNA?+ transfection reagent

Molecule delivered

mRNA

Applications

Vaccination / immunization
Cancer therapy
in vivo functional studies (Gene expression, CRISPR genome editing)

Targeted organs

All organs (depending on the injection route)

Injection routes

Various administration routes (systemic or local)
Intravenous / intramuscular / intraperitoneal and retro-orbital injections have been successfully tested

Number of injections in mice

1 mL is sufficient to perform at least 50 intravenous injections or 100 intramuscular injections in mice

Storage

Store in vivo-jetRNA?+ at 5 °C ± 3°C. Do not freeze.
Expiry date is indicated in the certificate of analysis and on the product.

Provided with

mRNA buffer

Summary

in vivo transfection reagents are the most powerful alternative to viral vectors for nucleic acid delivery. They are easy to use, cost-effective and considered as safe and efficient vehicles for RNA delivery. mRNA transfection is rapidly emerging as a promising method for nucleic acid-based therapy and offers an attractive substitute to plasmid DNA. Non-viral mRNA delivery methods have already proven their efficiency in vaccination through antigen presenting cells modification and in anti-cancer therapy by directly targeting malignant cells. The intrinsic advantage of mRNA-based immunotherapy relies on the self-adjuvant activity of mRNA and the fact that small amounts of encoded antigen are sufficient to obtain robust immune response.

in vivo-jetRNA?+ is a lipid-based transfection reagent composed of preformed liposomes specifically developed to deliver mRNA in vivo. This reagent can be used to target unique or multiple organs, by using systemic injection routes, in various animal models (mice, rat, etc.). mRNA delivery using in vivo-jetRNA?+ is user-friendly, with a simple 2-step protocol and can be used for vaccination purposes, anti-cancer studies, genome editing using CRISPR/Cas9 method or protein replacement.

Webinar: Next generation lipid-based delivery for mRNA therapeutics: in vivo-jetRNA?+

相關產品:

貨號

名稱

規(guī)格

101000051

jetOPTIMUs

0.1 ml

101000027

jetPRIME?

0.1 ml

101000036

INTERFERin?

0.1 ml

101000056

jetMESSENGER?

0.1 ml

101000010

PULSin?

0.4 ml

101000040

in vivo-jetPEI?

0.1 ml

101000122

In vivo-jetRNA?+ transfection reagent

1 mL